The role of endocannabinoids system in fatty liver disease and therapeutic potentials

The role of endocannabinoids system in fatty liver disease and therapeutic potentials

Non-alcoholic fatty liver disease (NAFLD) is a major cause of liver morbidity and mortality with no proven effective therapy as of yet. Its prevalence is increasing globally in parallel with obesity and metabolic syndrome pandemic. The endocannabinoid (EC) system has been implicated in the pathogene...

Full description

Bibliographic Details
Main Author: Khalid A Alswat
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2013-01-01
Series:The Saudi Journal of Gastroenterology
Subjects:
Cannabinoid receptors type 1
cannabinoid receptors type 2
endocannabinoids
endocannabinoids system
fatty liver disease
Online Access:http://www.saudijgastro.com/article.asp?issn=1319-3767;year=2013;volume=19;issue=4;spage=144;epage=151;aulast=Alswat

Internet

http://www.saudijgastro.com/article.asp?issn=1319-3767;year=2013;volume=19;issue=4;spage=144;epage=151;aulast=Alswat

Similar Items